见证奇点来临 在大家下意识 Say "No" 的地方找到机会。 文 丨 李梓楠 程曼祺 编辑 丨 程曼祺 1991 年出生的极壳外骨骼创始人孙宽和宇树创始人王兴兴一样，都不是履历亮眼的学霸型创业者。他 们所在的硬件领域不乏出身清北或者曾在海外名校深造的天才少年。王兴兴考研时因英语太差，落榜 浙江大学。孙宽的英语也不好，大多数投资人想不起他毕业于哪里。 以下文章来源于晚点科技 ，作者晚点团队 晚点科技 . 孙宽从小就沉迷于造东西和拆东西，家里开手机卖场，初中就会拆装手机、写程序。 上大学时，他一个人做光固化 3D 打印机，用半年时间，写了上万行代码，把一个本应由团队完成的 复杂硬件做通了。这件事给他两个感悟：没有什么东西是想得到，但做不出来的，只要愿意；自己解 决问题的能力好像很强。 这个挂念促使他愿意去做大部分人觉得 "不可能" 的品类。那段经历让他意识到，所谓不可能，只是多 数人没看到，这些不可能里往往蕴藏很多改变世界的机会。 孙宽自己也是一位户外运动爱好者。 在电机、运动控制算法和 AI 技术突变的情况下，大部分履历光鲜的天才都追逐同一个叙事：做更聪 明更强的机器替代人。孙宽则相反，做外骨骼增强人，而不是 ...

Financing Overview - A total of 27 financing events occurred in Shanghai this week, with 13 disclosing amounts totaling approximately 1.753 billion yuan [5][10] - The majority of financing events took place in the Pudong New Area, with 12 events, followed by Minhang District with 5 events [5] - The most common financing round was Series A, with 11 occurrences, followed by angel rounds with 8 [7] Company Dynamics - Weike Bio's patent for a detection method based on exogenous DNA insertion mutations was approved on November 5 [3] - DeYin Technology showcased at the Hong Kong Elderly Technology Expo on November 20 [3] - Hejian Technology and CAE Network partnered to establish a PCB design and digital chip simulation collaboration on December 1 [3] Hot Industry Focus - The National Medical Products Administration approved a disposable pressure monitoring cardiac pulsed electric field ablation catheter from Shanghai MicroPort on November 24 [4] - Novartis' innovative drug, Ripretinib tablets, received approval from the National Medical Products Administration on November 26 [4] - Anke Bio's Shanghai Innovation Research Institute and Shanghai Anke Huaze Pharmaceutical officially opened in Zhangjiang on November 27 [4][24] Notable Financing Events - Wunwen Qinqu completed nearly 500 million yuan in Series A+ financing on November 27, led by Zhuhai Technology Group and Futen Capital [13][14] - Hypershell completed 70 million USD in Pre-B and B round financing on November 27, with participation from various investors [16][17] - Kaisi Kedi completed 300 million yuan in Series B financing on November 28, led by Guotou Xiandao [18][19] - Aoyi Technology completed over 100 million yuan in B+++ round financing on November 28, exclusively invested by listed company Redik [20][21] - Kaiwuji completed a 100 million yuan angel round financing on November 26, led by IDG Capital and BlueRun Ventures [22][23] Policy and Regulatory Developments - The Shanghai government introduced 22 measures to support the high-quality development of the biopharmaceutical industry, focusing on innovation and regulatory reforms [25]

Core Insights - Hypershell, a Chinese exoskeleton robotics company, has successfully completed Pre-B and B funding rounds, raising a total of $70 million (approximately 495 million RMB) with a post-investment valuation nearing $400 million [1][6] - The company focuses on consumer-grade exoskeletons designed to enhance physical capabilities, making them accessible for outdoor enthusiasts and professionals in various fields such as industrial handling and rehabilitation [1][9] - Hypershell is the first company globally to mass-produce and sell consumer-grade exoskeletons, targeting ordinary consumers rather than military or medical markets [1][11] Company Overview - Founded by Sun Kuan in 2021, Hypershell aims to create affordable and portable exoskeletons for everyday users, addressing the growing need for enhanced mobility in an increasingly sedentary society [2][3][4] - The initial team comprised experts from robotics, ergonomics, and AI, focusing on balancing weight, cost, and assistive performance in their product development [4][5] Product Development - The team developed the Omega architecture, featuring a single motor drive system, which significantly reduced the weight of the exoskeleton from the industry standard of over 10 kg to just 1.8 kg [5][6] - By utilizing self-developed core components, the overall cost of the exoskeleton was reduced to one-tenth of traditional models, paving the way for a target price point around $1,000 [6][9] - The first product, Hypershell Go, was launched in 2023, successfully raising $1.23 million through crowdfunding on Kickstarter, with 40% of backers from the U.S. [6][7] Market Potential - The global exoskeleton market is projected to reach $5.8 billion by 2028, with a compound annual growth rate (CAGR) of approximately 47.7% from 2025 to 2028; the Chinese market is expected to reach around 4.2 billion RMB by 2025, maintaining a growth rate of about 50% [10] - Despite rapid growth, the industry remains in its early stages, with low penetration rates, particularly in China, where the market has evolved from a few billion RMB to a more substantial scale [10][11] Competitive Landscape - The exoskeleton market features a mix of traditional manufacturers focused on medical and industrial applications and emerging startups targeting consumer-grade wearable technology [10][11] - Hypershell distinguishes itself by designing products specifically for ordinary consumers from the outset, focusing on comfort, weight, affordability, and ease of use [11] Technological Trends - Advancements in materials, sensors, and battery technology are driving the evolution of exoskeletons from specialized equipment to consumer products, with applications expanding into everyday activities [9][12] - Key technological developments include lighter and more efficient drive systems, improved human motion recognition algorithms, modular structures, safety systems, and specialized algorithms for specific activities [12][13][14]

Core Insights - Hypershell, a consumer-grade exoskeleton brand, has completed a total of $70 million in Pre-B and B round financing, with a post-investment valuation nearing $400 million [4][8][16] - The company aims to enhance human mobility through innovative technology, addressing the decline in physical activity due to urbanization and aging [5][20] - Hypershell has developed the world's first single-motor driven exoskeleton system, significantly reducing costs and weight, making the product accessible at a consumer price point [8][9] Financing and Growth - The recent financing will be used for research and development, product design, supply chain production, global marketing, and talent acquisition [14][16] - Hypershell has established sales channels in over 70 countries, with cumulative shipments reaching tens of thousands [10][12] Market Strategy - The company follows a global market strategy, initially focusing on outdoor enthusiasts in mature markets before expanding into domestic channels [12][20] - The launch of the Hypershell Go on Kickstarter raised $1.23 million, becoming a bestseller, with 40% of backers from the U.S. [8][9] Competitive Landscape - As the consumer-grade exoskeleton market grows, competitors like Cheng Tian Technology and Skip are emerging, indicating a challenging future for Hypershell [18] - The key to success in this sector includes user interaction, lightweight design, supply chain management, and precise market positioning [18] Future Outlook - The potential for consumer-grade exoskeletons is significant, with applications in outdoor activities, elder assistance, and commuting [18][20] - Hypershell's mission is to enhance human capabilities rather than replace them, differentiating it from other robotics companies [20]

Core Insights - The article highlights the rapid integration of consumer-grade exoskeletons into everyday life, with Hypershell securing $70 million in Pre-B and B round financing, achieving a post-investment valuation of nearly $400 million, indicating strong market potential [3][4]. Financing and Investment - Hypershell's recent financing rounds show significant capital aggregation, with the B round led by Guanghe Venture Capital and Wuyuan Capital, and participation from Meituan Longzhu. The Pre-B round was led by Monolith, with continued investment from Wuyuan Capital [3][4]. - The company aims to utilize the $70 million funding for R&D, production, marketing, and talent acquisition, essential for scaling operations in the exoskeleton industry [5][6]. Company Overview - Founded in late 2021, Hypershell is the first startup to transition exoskeleton applications from medical and industrial fields to consumer markets. The founder, Sun Kuan, has a decade of experience in robotics and exoskeleton research [3][4]. - The company has developed a pioneering single-motor exoskeleton system, significantly reducing costs and weight, allowing for a consumer price point of around $1,000 [4][5]. Product Development and Market Strategy - Hypershell launched its first consumer-grade exoskeleton, Hypershell Go, on Kickstarter in March 2023, raising $1.23 million and gaining support from 2,638 global users, with 40% from the U.S. [4][5]. - The company plans to officially launch the Hypershell X series in China in August 2024, following a successful global rollout [5][6]. Competitive Landscape - The consumer-grade exoskeleton market is becoming competitive, with companies like Cheng Tian Technology and others entering the space. Hypershell's strong investor backing positions it well, but the industry faces uncertainties [6][7]. - The success of consumer-grade exoskeletons will depend on factors such as user interaction, product lightweighting, supply chain management, and precise scene definition [7][8]. Technological Innovation - Hypershell's MotionEngine, which incorporates AI capabilities, is a key competitive advantage, enabling the product to adapt to various user types and complex scenarios [7][8]. - The company’s advancements in AI motion intent recognition and human-machine interaction may provide a foundation for future developments in humanoid robotics [7][8].

Core Viewpoint - Hypershell has successfully completed a $70 million Pre-B and B round financing, achieving a post-financing valuation of nearly $400 million, positioning itself as a pioneer in the consumer-grade exoskeleton market [3][5]. Financing and Valuation - Hypershell raised $70 million in its Pre-B and B round financing, led by Guanghe Venture Capital and Wuyuan Capital, with participation from Meituan Longzhu and other existing investors [3]. - The company's post-financing valuation is approximately $400 million [3]. Product Development and Innovation - Hypershell is the first company globally to achieve large-scale production and commercialization of consumer-grade exoskeletons, overcoming skepticism in the industry [3][5]. - The Hypershell X series, the company's first mass-produced product, features a peak power motor of 800W, effectively reducing the user's physical burden by 30% [5]. - The product has a range of 15-17.5 kilometers in typical use cases, catering to long-distance walking or daily work needs [5]. - The latest release, Hypershell X Ultra, showcases significant advancements in its power system and AI algorithms, including a second-generation AI motion intent recognition algorithm that can adapt to 12 different postures [6][7]. Industry Recognition - Hypershell's products have received international accolades, including the "Best Innovation Product Award" at CES 2025 and IFA 2025, highlighting their industrial design and technological innovation [5][6]. - The Hypershell Ultra series is the first exoskeleton product to receive SGS certification, establishing a benchmark for performance parameters in a market often criticized for lack of standards [7]. Market Potential and Future Outlook - Investors express confidence in Hypershell's ability to lead the consumer-grade exoskeleton market, driven by its strong patent portfolio and innovative capabilities [9][10]. - The company is positioned to redefine the category of consumer-grade exoskeletons, with significant growth potential as the industry evolves with advancements in robotics and AI [9][10].

Core Viewpoint - The article discusses the emergence of Hypershell, a consumer-grade exoskeleton brand, which has recently completed $70 million in Pre-B and B round financing, achieving a post-investment valuation close to $400 million [2][5]. Group 1: Company Overview - Hypershell was founded at the end of 2021 and is the first company to bring exoskeleton products from medical and industrial fields to the consumer market [3]. - The founder, Sun Kuan, has a diverse background in robotics hardware management, exoskeleton academic research, and overseas hardware brand creation [3]. - The team consists of experts in robotics, ergonomics, and AI algorithms, with experience from leading hardware and robotics companies [3]. Group 2: Product Development and Innovation - In 2023, Hypershell invented the world's first single-motor-driven exoskeleton system, significantly reducing the cost and weight of exoskeletons by half [5]. - The company launched its first consumer-grade exoskeleton product, Hypershell Go, on Kickstarter, raising $1.23 million and attracting 2,638 supporters, with 40% from the U.S. [5][6]. - The latest product, Hypershell X Ultra, features a second-generation AI motion intention recognition algorithm, providing 2.5 times the battery life under the same capacity [6]. Group 3: Market Strategy and Expansion - Hypershell has established sales channels in over 70 countries, with a cumulative shipment of tens of thousands of units [7]. - The company adopts a global market strategy, initially focusing on outdoor enthusiasts in mature outdoor cultures in Europe and the U.S. before entering the domestic market [9]. - The recent launch of Hypershell X in China marks the company's entry into the domestic market, leveraging established infrastructure [9]. Group 4: Funding and Financial Outlook - The recent $70 million financing will be used for various business needs, including R&D, product design, supply chain production, marketing, and talent recruitment [10]. - Hypershell has gained significant attention in the primary market, being recognized as a star startup due to its innovative consumer-grade products and global strategy [11][12]. Group 5: Competitive Landscape and Future Challenges - As the consumer-grade exoskeleton market grows, competitors like Cheng Tian Technology and Skip are emerging, making the future path for Hypershell uncertain [15]. - Sun Kuan emphasizes the importance of excelling in multiple areas, including user interaction, lightweight design, supply chain management, and precise scene definition to maintain a competitive edge [15]. - The potential for consumer-grade exoskeletons to evolve from niche products to everyday necessities is highlighted as a key challenge for the industry [15][16].